Drug search by name

Korlym and Hepatic impairment

Result of checking the interaction of drug Korlym and disease Hepatic impairment for safety when used together.

Check result:

Korlym <> Hepatic impairment

Relevance: 23.07.2019 Reviewer: Shkutko P.M., M.D., in

When checking interaction based on authoritative sources Drugs.com, Rxlist.com, Webmd.com, Medscape.com there are contraindications or side effects that may cause harm or increase the negative effect from drug use in presence of concomitant diseases.

Consumer:

There is limited information on the safety of mifepristone in patients with mild to moderate hepatic impairment, hence the manufacturers recommend that the maximum dose should not exceed 600 mg per day. The use of mifepristone is not recommended in patients with severe hepatic disease as the pharmacokinetics in these patients have not been studied.

Korlym

Generic Name: mifepristone

Brand Name: Korlym, Mifeprex

Synonyms: n.a.

What is Korlym?